CAS 32703-82-5|6-tert-Butyl-2,3-naphthalenedicarbonitrile

Introduction:Basic information about CAS 32703-82-5|6-tert-Butyl-2,3-naphthalenedicarbonitrile, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common Name6-tert-Butyl-2,3-naphthalenedicarbonitrile
CAS Number32703-82-5Molecular Weight234.29600
Density1.11g/cm3Boiling Point429.7ºC at 760 mmHg
Molecular FormulaC16H14N2Melting Point185-189ºC(lit.)
MSDSUSAFlash Point206.6ºC
Symbol
GHS07
Signal WordWarning

Names

Name6-tert-Butyl-2,3-naphthalenedicarbonitrile
SynonymMore Synonyms

BiologicalActivity

DescriptionBRD9876 is the “rigor” inhibitor that locks kinesin-5 (Eg5) in a state with enhanced microtubules (MTs) binding, leading to bundling and stabilization of MTs. BRD9876 interacts with the tyrosine 104 residue that is part of the α4-α6 allosteric binding pocket. BRD9876 specifically targets microtubule-bound Eg5 and selectively inhibits myeloma over CD34 cells. BRD9876 has the potential for multiple myeloma (MM) research[1][2][3][4].
Related CatalogResearch Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>Microtubule/TubulinSignaling Pathways >>Cell Cycle/DNA Damage >>KinesinSignaling Pathways >>Cytoskeleton >>Microtubule/TubulinSignaling Pathways >>Cytoskeleton >>Kinesin
In VitroBRD9876 (10 μM; 24 hours) reveales rapid arrest of cells at the G2/M phase starting as early as 2h of treatment in MM1S cells[1]. BRD9876 exhibits approximately 3-fold selectivity for MM1S myeloma cells (IC50=3.1 μM) over CD34+ derived hematopoietic cells (IC50=9.1 μM)[1]. BRD9876 (0.1, 1, 10, 100 uM) is able to overcome, in MM1S cells, stromal resistance of bone marrow stromal cells (BMSCs) from MM bone marrow aspirates but only minimal effects are observed with BRD9876 against primary MM cells[1]. BRD9876 is completely ineffective at inhibiting the basal ATPase activity of Eg5, in contrast to loop L5-binding monastrol or α4/α6-binding BI8 which shows greater activity against basal Eg5 ATPase activity[1]. Cell Cycle Analysis[1] Cell Line: MM1S cells and CD34 hematopoietic cells Concentration: 10 μM Incubation Time: 24 hours Result: Revealed rapid arrest of cells at the G2/M phase starting as early as 2h of treatment in MM1S cells. Showed markedly less G2/M arrest in CD34 hematopoietic cells.
References

[1]. Shrikanta Chattopadhyay, et al. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Rep. 2015 Feb 10;10(5):755-770.

[2]. Chieh-Ting Fang, et al. HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors. Cell Death Dis. 2020 Sep 1;11(8):715.

[3]. Anke Maes, et al. The therapeutic potential of cell cycle targeting in multiple myeloma. Oncotarget. 2017 Jun 28;8(52):90501-90520.

[4]. Geng-Yuan Chen, et al. Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity. ACS Chem Biol. 2017 Apr 21;12(4):1038-1046.

Chemical & Physical Properties

Density1.11g/cm3
Boiling Point429.7ºC at 760 mmHg
Melting Point185-189ºC(lit.)
Molecular FormulaC16H14N2
Molecular Weight234.29600
Flash Point206.6ºC
Exact Mass234.11600
PSA47.58000
LogP3.88066
Index of Refraction1.603
InChIKeyMKILROQBJOOZKC-UHFFFAOYSA-N
SMILESCC(C)(C)c1ccc2cc(C#N)c(C#N)cc2c1

Safety Information

Symbol
GHS07
Signal WordWarning
Hazard StatementsH302-H312-H332
Precautionary StatementsP280
Personal Protective Equipmentdust mask type N95 (US);Eyeshields;Gloves
Hazard CodesXn: Harmful;
Risk Phrases20/21/22
Safety Phrases36
RIDADRNONH for all modes of transport
HS Code2926909090

Customs

HS Code2926909090
SummaryHS:2926909090 other nitrile-function compounds VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Synonyms

6-tert-butylnaphthalene-2,3-dicarbonitrile
MFCD00209558
CAS 109423-00-9|HEXAHYDRO-2,6-BIS(2,2,6,6-TETRAMETHYL-4-PIPERIDINYL)-1H,4H,5H,8H-2,3A,4A,6,7A
CAS 154-86-9|Phenylephrine hydrochloride
Recommended......
TOP